Fetal and Maternal Safety Considerations for In Utero Therapy Clinical Trials: iFeTiS Consensus Statement
- PMID: 33069884
- PMCID: PMC7647692
- DOI: 10.1016/j.ymthe.2020.10.012
Fetal and Maternal Safety Considerations for In Utero Therapy Clinical Trials: iFeTiS Consensus Statement
Keywords: In utero stem cell transplantation; adverse event; clinical trial; fetal; fetal therapy; maternal; safety.
References
-
- Schneider H., Faschingbauer F., Schuepbach-Mallepell S., Körber I., Wohlfart S., Dick A., Wahlbuhl M., Kowalczyk-Quintas C., Vigolo M., Kirby N. Prenatal Correction of X-Linked Hypohidrotic Ectodermal Dysplasia. N. Engl. J. Med. 2018;378:1604–1610. - PubMed
-
- Aina-Mumuney A.J., Holcroft C.J., Blakemore K.J., Bienstock J.L., Hueppchen N.A., Milio L.A., Crino J.P. Intrahepatic vein for fetal blood sampling: one center’s experience. Am. J. Obstet. Gynecol. 2008;198:387.e1–387.e6. - PubMed
-
- Akolekar R., Beta J., Picciarelli G., Ogilvie C., D’Antonio F. Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Ultrasound Obstet. Gynecol. 2015;45:16–26. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
